Loading clinical trials...
Loading clinical trials...
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Conditions
Interventions
Lubiprostone
Placebo
Locations
142
United States
North Alabama Research Center
Athens, Alabama, United States
Innovative Clinical Trials, Inc.
Birmingham, Alabama, United States
Achieve Clinical Research
Birmingham, Alabama, United States
Alabama Clinical Therapeutics
Birmingham, Alabama, United States
G&L Research, LLC
Foley, Alabama, United States
Healthscan Research
Montgomery, Alabama, United States
Start Date
December 1, 2010
Primary Completion Date
November 1, 2011
Completion Date
November 1, 2011
Last Updated
February 11, 2020
NCT06385561
NCT04876508
NCT00620061
Lead Sponsor
Sucampo Pharma Americas, LLC
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions